Related Experiment Video
Updated: Jun 26, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Kernicterus in the 21st century: frequently asked questions
1Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital, Stanford, CA, USA. bhutani@stanford.edu
Insights
Severe neonatal hyperbilirubinemia poses a risk for kernicterus, a preventable brain injury. Current estimates suggest a significant risk of chronic kernicterus in infants with total serum bilirubin levels exceeding 30 mg/dL.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
- Public Health
Background:
- Acute kernicterus is a preventable neonatal brain injury resulting from delayed management of hyperbilirubinemia.
- Practitioners frequently question the risks and timing of bilirubin-related neurotoxicity in infants.
- There is ongoing concern regarding the re-emergence and incidence of kernicterus in the United States.
Purpose of the Study:
- To address critical questions regarding bilirubin neurotoxicity in infants.
- To evaluate the risk and incidence of kernicterus and severe neonatal hyperbilirubinemia.
- To determine safe bilirubin thresholds and assess sequelae of hyperbilirubinemia.
Main Methods:
- Review and analysis of available data and evidence on neonatal hyperbilirubinemia.
- Estimation of the current risk of kernicterus in infants with elevated total serum bilirubin (TSB).
- Assessment of the impact of the 1994 American Academy of Pediatrics Guidelines.
Main Results:
- The study estimates the current risk of chronic kernicterus to be approximately 1 in 7 for infants with TSB >30 mg/dL (513 micromol/L).
- Addresses questions on whether bilirubin damages healthy infant brains and the specific TSB thresholds for neurotoxicity.
- Discusses the incidence of kernicterus and severe neonatal hyperbilirubinemia in the current era.
Conclusions:
- Delayed management of neonatal hyperbilirubinemia can lead to preventable brain injury.
- A TSB level >30 mg/dL poses a substantial risk for chronic kernicterus.
- Further research and clinical vigilance are necessary to prevent kernicterus and its sequelae.
Abstract:
Acute kernicterus remains a clinical emergency and its delayed management represents an easily preventable neonatal brain injury. Yet, practitioners encounter recurrent questions regarding the risk and timing of bilirubin-related neurotoxicity. These include the following: does bilirubin damage the brain of healthy infants? Is there a re-emergence of kernicterus in the United States? Was kernicterus previously prevented in the United States? What was the public health impact of 1994 American Academy of Pediatrics Guidelines? What is the current incidence of kernicterus and severe neonatal hyperbilirubinemia? What is the estimated risk of kernicterus in infants with excessive hyperbilirubinemia? Is there a specific bilirubin threshold total serum bilirubin (TSB) value for neurotoxicity? Are there sequelae of severe or prolonged moderate hyperbilirubinemia in the absence of recognized acute bilirubin encephalopathy? Can we define a bilirubin level that is safe in newborns? We address these questions in the context of available data and evidence, and estimate the current risk of chronic kernicterus is about one in seven in infants with TSB >30 mg per 100 ml (513 micromol l(-1)).
Related Concept Videos
Jaundice
Cirrhosis II: Pathophysiology
Hepatic Encephalopathy
Cirrhosis I: Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Glaucoma: Overview

